| EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors YL Choi, M Soda, Y Yamashita, T Ueno, J Takashima, T Nakajima, ... New England Journal of Medicine 363 (18), 1734-1739, 2010 | 1124 | 2010 |
| RET, ROS1 and ALK fusions in lung cancer K Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ... Nature Medicine 18 (3), 378-381, 2012 | 1076 | 2012 |
| Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts T Nakamura, Y Imai, T Matsumoto, S Sato, K Takeuchi, K Igarashi, ... Cell 130 (5), 811-823, 2007 | 781 | 2007 |
| KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer K Takeuchi, YL Choi, Y Togashi, M Soda, S Hatano, K Inamura, S Takada, ... Clinical cancer research 15 (9), 3143-3149, 2009 | 717 | 2009 |
| A mouse model for EML4-ALK-positive lung cancer M Soda, S Takada, K Takeuchi, YL Choi, M Enomoto, T Ueno, H Haruta, ... Proceedings of the National Academy of Sciences 105 (50), 19893, 2008 | 573 | 2008 |
| CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study T Seto, K Kiura, M Nishio, K Nakagawa, M Maemondo, A Inoue, T Hida, ... The lancet oncology 14 (7), 590-598, 2013 | 550 | 2013 |
| Frequent inactivation of A20 in B-cell lymphomas M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ... Nature 459 (7247), 712-716, 2009 | 525 | 2009 |
| Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts K Takeuchi, YL Choi, M Soda, K Inamura, Y Togashi, S Hatano, ... Clinical cancer research 14 (20), 6618-6624, 2008 | 503 | 2008 |
| EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers K Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ... Journal of Thoracic Oncology 3 (1), 13, 2008 | 503 | 2008 |
| EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ... Modern pathology 22 (4), 508-515, 2009 | 467 | 2009 |
| Identification of novel isoforms of the EML4-ALK transforming gene in non–small cell lung cancer YL Choi, K Takeuchi, M Soda, K Inamura, Y Togashi, S Hatano, ... Cancer research 68 (13), 4971-4976, 2008 | 453 | 2008 |
| Adsorption of Acid Blue 193 from aqueous solutions onto BTMA-bentonite AS Özcan, B Erdem, A Özcan Colloids and Surfaces A: Physicochemical and Engineering Aspects 266 (1-3 …, 2005 | 425 | 2005 |
| Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients T Oyama, K Yamamoto, N Asano, A Oshiro, R Suzuki, Y Kagami, ... Clinical cancer research 13 (17), 5124-5132, 2007 | 409 | 2007 |
| Somatic RHOA mutation in angioimmunoblastic T cell lymphoma M Sakata-Yanagimoto, T Enami, K Yoshida, Y Shiraishi, R Ishii, Y Miyake, ... Nature genetics 46 (2), 171, 2014 | 360 | 2014 |
| Integrated molecular analysis of adult T cell leukemia/lymphoma K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi, T Shimamura, J Yasunaga, ... Nature genetics 47 (11), 1304, 2015 | 339 | 2015 |
| Structural determinant of TRPV1 desensitization interacts with calmodulin M Numazaki, T Tominaga, K Takeuchi, N Murayama, H Toyooka, ... Proceedings of the National Academy of Sciences 100 (13), 8002-8006, 2003 | 327 | 2003 |
| Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers K Kataoka, Y Shiraishi, Y Takeda, S Sakata, M Matsumoto, S Nagano, ... Nature 534 (7607), 402, 2016 | 289 | 2016 |
| KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only Y Togashi, M Soda, S Sakata, E Sugawara, S Hatano, R Asaka, ... PloS one 7 (2), e31323, 2012 | 239 | 2012 |
| Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib R Katayama, L Friboulet, S Koike, EL Lockerman, TM Khan, JF Gainor, ... Clinical cancer research 20 (22), 5686-5696, 2014 | 221 | 2014 |
| Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype R Suzuki, Y Kagami, K Takeuchi, M Kami, M Okamoto, R Ichinohasama, ... Blood 96 (9), 2993-3000, 2000 | 221 | 2000 |
Yuki TogashiPathology Project for Molecular Targets, The Cancer Institute, JFCRVerified email at jfcr.or.jp
